- Filed
- May 5, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 28, 2025 | 51.97M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $1.97B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $1.25B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $21.4M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $0 |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.18B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $535.5M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.49B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.86B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $8B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $3.41B |
| Rd Expense | Q1 2025 · Mar 31, 2025 | $33.6M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $6.4M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 32.2M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $3.2M |
| Capex | Q1 2025 · Mar 31, 2024 | $10.5M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.49B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.49B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.71 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.71 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $103.7M |
| Net Income | Q1 2025 · Mar 31, 2024 | $22.8M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $29.1M |
| Revenue | Q1 2025 · Mar 31, 2024 | $392.3M |